본문으로 바로가기

의료진 소개

조영주 의사

조영주 교수


알레르기내과 관심의료진 등록

전문 진료 분야

기관지천식, 알레르기성비염, 기침, 두드러기, 기타면역계 이상질환, 코로나후유증 클리닉(금 오전) 기관지천식, 알레르기성비염, 기침, 두드러기, 기타면역계 이상질환, 코로나 후유증 클리닉(금 오전)

진료 일정

학력 및 경력사항

학력사항

  • 이화여대 의학박사학위 취득

교육 및 연구경력

  • 2003-현재  | 이화여자대학교 의과대학 정교수
  • 2015-2017  | 이화의료원 위탁운영 서남병원 병원장
  • 2013-2015  | 이화여자대학교 의료원 기획조정실장
  • 2009-2012  | 서울시 아토피.천식교육정보센터 센터장
  • 2008-2013  | 이대목동병원 고객만족실 실장
  • 2007-2008  | 미국 뉴욕 업스테이트병원 방문교수
  • 2000-2004  | 이대목동병원 내과 과장
  • 1998-2003  | 이화여자대학교 의과대학 알레르기내과 부교수
  • 1994-1995  | 미국 아이오와대학 알레르기내과 방문교수
  • 1993-1998  | 이화여자대학교 의과대학 알레르기내과 조교수
  • 1990-1993  | 서울아산병원 생명과학연구소 선임연구원
  • 1988-1990  | 서울대병원 알레르기내과 전임의

기타 학술 관련 경력

  • 현재  | AARD(Allergy Asthma Respiratory Disease: 대한천식알레르기학회 및 소아알레르기학회 공동 국내잡지) 편집위원장
  • 현재  | 한국천식알레르기협회 사무총장
  • 현재  | 한국천식협회 운영 천식 학교 교장( Post graduate Asthma School)
  • 대한 천식 및 알레르기 학회 보험이사, 홍보이사, 총무이사 역임
  • 대한내과학회. 대한 천식 및 알레르기학회 정회원. 평위원

논문

  •  Association Between Clinical Burden and Blood Eosinophil Counts in Asthma: Findings From a Korean Adult Asthma Cohort.  JOURNAL OF KOREAN MEDICAL SCIENCE. 2022, v.37 no.7, e57. 
  •  Association of genetic variants of oxidative stress responsive kinase 1 (OXSR1) with asthma exacerbations in non-smoking asthmatics.  BMC Pulmonary Medicine. 2022, v.22 no.1, 3. 
  •  Multicenter Prospective Observational Study to Evaluate the Therapeutic Effect and Safety of a Combination of Montelukast and Levocetirizine for Allergic Rhinitis when Administered to Patients with Allergic Rhinitis and Asthma.  International Archives of Allergy and Immunology. 2022, v.183 no.12, 1251-1258. 
  •  A Randomized, Noninferiority Trial Comparing ICS thorn LABA with ICS plus LABA plus LAMA in Asthma-COPD Overlap (ACO) Treatment: The ACO Treatment with Optimal Medications (ATOMIC) Study.  JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2021, v.9 no.3, 1304-. 
  •  Discontinuation of inhaled corticosteroids in patients with controlled asthma The DISCO (Discontinuation of Inhaled Steroid in Controlled asthmatics Over 6 months) study.  ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. 2021, v.127 no.1, 123-. 
  •  Risk of Neuropsychiatric Diseases According to the Use of a Leukotriene Receptor Antagonist in Middle-Aged and Older Adults with Asthma: A Nationwide Population-Based Study Using Health Claims Data in Korea.  JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2021, v.9 no.12, 4290-4297. 
  •  구강알레르기증후군 환자에서 벌 화분(bee pollen) 섭취 후 발생한 아나필락시스 1예.  Allergy Asthma & Respiratory Diseases. 2020, v.8 no.4, 227-230. 
  •  혈중 호염기구 수에 따른 성인 천식의 임상 양상 분석 및 호기 응축물 내 사이토카인과의 연관성 분석.  Allergy Asthma & Respiratory Diseases. 2020, v.8 no.3, 119-126. 
  •  Characteristics of Adult Severe Refractory Asthma in Korea Analyzed From the Severe Asthma Registry.  ALLERGY ASTHMA & IMMUNOLOGY RESEARCH. 2019, v.11 no.1, 43-54. 
  •  Efficacy of the HLA-B*58:01 Screening Test in Preventing Allopurinol-Induced Severe Cutaneous Adverse Reactions in Patients with Chronic Renal Insufficiency-A Prospective Study.  JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2019, v.7 no.4, 1271-1276. 
  •  High ACT score is not sufficient to reduce the risk of asthma exacerbations in asthma with low lung function.  RESPIRATORY MEDICINE. 2019, v.150, 38-44. 
  •  Inhaled Corticosteroids in Asthma and the Risk of Pneumonia.  ALLERGY ASTHMA & IMMUNOLOGY RESEARCH. 2019, v.11 no.6, 795-805. 
  •  Novel Trajectories for Identifying Asthma Phenotypes: A Longitudinal Study in Korean Asthma Cohort, COREA.  JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2019, v.7 no.6, 1850-. 
  •  A Randomized, Multicenter, Double-blind, Phase III Study to Evaluate the Efficacy on Allergic Rhinitis and Safety of a Combination Therapy of Montelukast and Levocetirizine in Patients With Asthma and Allergic Rhinitis.  CLINICAL THERAPEUTICS. 2018, v.40 no.7, 1096-1107. 
  •  Clinical course of asthma patients with H1N1 influenza infection and oseltamivir.  MINERVA MEDICA. 2018, v.109 no.1, 7-14. 
  •  Different clinical features of anaphylaxis according to cause and risk factors for severe reactions.  ALLERGOLOGY INTERNATIONAL. 2018, v.67 no.1, 96-102. 
  •  Heterogeneity of asthma and COPD overlap.  International Journal of COPD. 2018, v.13, 1251-1260. 
  •  Lactobacillus plantarum-derived Extracellular Vesicles Protect Atopic Dermatitis Induced by Staphylococcus aureus-derived Extracellular Vesicles.  ALLERGY ASTHMA & IMMUNOLOGY RESEARCH. 2018, v.10 no.5-6, 516-532. 
  •  A metagenomic analysis provides a culture-independent pathogen detection for atopic dermatitis.  Allergy, Asthma and Immunology Research. 2017, v.9 no.5, 453-461. 
  •  Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study.  BMC PULMONARY MEDICINE. 2017, v.17. 
  •  House Dust Mite-Derived Chitin Enhances Th2 Cell Response to Inhaled Allergens, Mainly via a TNF-alpha-Dependent Pathway.  ALLERGY ASTHMA & IMMUNOLOGY RESEARCH. 2016, v.8 no.4, 362-374. 
  •  Relation of serum and sputum IL-33 levels with sputum inflammatory cells and lung function in bronchial asthma compared to normal controls and COPD.  ALLERGY. 2016, v.71, 7-7. 
  •  Classification and implementation of asthma phenotypes in elderly patients.  ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. 2015, v.114 no.1, 18-22. 
  •  Dominant Proportion of Staphylcoccus Aureus in the Skin of Atopic Dermatitis Patients through Metagenomic Analysis.  JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2015, v.135 no.2, AB261-AB261. 
  •  INHALED SALMETEROL/FLUTICASONE PROPIONATE IS MORE EFFECTIVE THAN FLUTICASONE PROPIONATE ALONE AT ACHIEVING TOTAL ASTHMA CONTROL IN ASIAN PATIENTS: A POST HOC ANALYSIS OF THE GOAL STUDY.  RESPIROLOGY. 2015, v.20, 13-13. 
  •  INHALED SALMETEROL/FLUTICASONE PROPIONATE IS MORE EFFECTIVE THAN FLUTICASONE PROPIONATE ALONE AT ACHIEVING WELL-CONTROLLED ASTHMA IN ASIAN PATIENTS: A POST HOC ANALYSIS OF THE GOAL STUDY.  RESPIROLOGY. 2015, v.20, 13-13. 
  •  Patients' beliefs and behaviors related to treatment adherence in patients with asthma requiring maintenance treatment in Asia.  Journal of Asthma. 2014, v.51 no.6, 652-659. 
  •  Risk factors for asthma-related healthcare use: Longitudinal analysis using the NHI claims database in a Korean asthma cohort.  PLoS ONE. 2014, v.9 no.11. 
  •  The correlation between the bronchial hyperresponsiveness to methacholine and asthma like symptoms by GINA questionnaires for the diagnosis of asthma.  BMC PULMONARY MEDICINE. 2014, v.14.